The emerging nosocomial pathogens cryptosporidium, escherichia coli O157:H7, helicobacter pylori, and hepatitis C: Epidemiology, environmental survival, efficacy of disinfection, and control measures

Infection Control and Hospital Epidemiology

Volumn 22, Issue 5, 2001, Pages 306-315

  Weber, D J ^a   Rutala, W A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CRYPTOSPORIDIUM PARVUM; DISEASE TRANSMISSION; DISINFECTION; ESCHERICHIA COLI O157; FOOD CONTAMINATION; HEALTH CARE PERSONNEL; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; NONHUMAN; WATER CONTAMINATION;

EID: 0034976089     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501907     Document Type: Article

References (182)

1. Factors in the emergence of infectious diseases
2. Travel and the emergence of infectious diseases
3. Unusual nosocomial pathogens
4. Cryptosporidial diarrhoea in AIDS and its treatment
5. Cryptosporidiosis in patients with hematologic malignancies
6. Cryptosporidiosis in immunocompetent patients
7. Surveillance for waterborne-disease outbreaks-United States, 1997-1998
8. Prevention Foodborne outbreak of diarrheal illness associated with Cryptosporidium parvum-Minnesota, 1995
9. An outbreak of cryptosporidiosis linked to a foodhandler
10. Outbreaks of Escherichia coli O157:H7 infection cryptosporidiosis associated with drinking unpasteurized apple cider - Connecticut and New York, October 1996
11. Swimming-associated cryptosporidiosis
12. An outbreak of cryptosporidiosis associated with a resort swimming pool
13. Outbreak of gastroenteritis associated with an interactive water fountain at a beachside park - Florida, 1999
14. Human cryptosporidiosis associated with an epizootic in calves
15. Cryptosporidiosis
16. Cryptosporidiosis: An emerging, highly infectious threat
17. Cryptosporidiosis
18. Emerging enteric protozoa: Cryptosporidium, Cyclospora, and Microsporidia
19. The infectivity of Cryptosporidium parvum in healthy volunteers
20. Reconciliation of microbial risk models and outbreak epidemiology: The case of the Milwaukee outbreak
21. Environmental ecology of Cryptosporidium and public health implications
22. Prevalence, detection and control of Cryptosporidium parvum in food
23. Human cryptosporidiosis: A possible case of hospital cross infection
24. Cryptosporidiosis in hospital personnel: Evidence for person-to-person transmission
25. Hospital-acquired cryptosporidiosis in a bone marrow transplantation unit
26. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: Possible association with malnutrition and nosocomial infection
27. An outbreak of Cryptosporidium diarrhea in a pediatric hospital
28. Nosocomial outbreak of cryptosporidiosis in AIDS patients
29. Cryptosporidiosis in immuno-compromised patients in a Turkish university hospital
30. Cryptosporidiosis among children attending day-care centers - Georgia, Pennsylvania, Michigan, California, New Mexico
31. Outbreak of cryptosporidiosis in a day-care center
32. Outbreak of diarrhea in a day care center with spread to household members: The role of Cryptosporidium
33. An outbreak of cryptosporidiosis in a day-care center in Georgia
34. Nosocomial transmission of Cryptosporidium in a veterinary hospital
35. Water quality laws and waterborne diseases: Cryptosporidium and other emerging pathogens
36. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply
37. Cryptosporidiosis: An outbreak associated with drinking water despite state-of-the-art water treatment
38. Aging of Cryptosporidium parvum oocysts in river water and their susceptibility to disinfection by chlorine and monochloramine
39. Survival of Cryptosporidium parvum oocysts under various environmental pressures
40. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes
41. Effect of drying on the infectivity of cryptosporidia-laden calf feces for 3- to-7-day-old mice
42. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts
43. Gaseous disinfection of Cryptosporidium parvum oocysts
44. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
45. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recepients: Recommendations of the CDC, the Infectious Disease Society of America, and the America Society of Blood and arrow Transplantation
46. Cryptosporidiosis in water supplies
47. Guideline for isolation precautions in hospitals
48. Risk of Cryptosporidium parvum transmission between hospital roommates
49. Emerging foodborne diseases
50. Foodborne diseases: Emerging pathogens and trends
51. Food-borne diseases in the global village what's on the plate for the 21st century
52. Food-related illness and death in the United States
53. Emerging foodborne pathogens: Escherichia coli O157:H7 as a model of entry of a new pathogen into the food supply of the developed world
54. Escherichia coli O157:H7 as an emerging foodborne pathogen: A literature review
55. Hemorrhagic colitis associated with a rare Escherichia coli serotype
56. Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing
57. Pathogenic Escherichia coli O157:H7: A model for emerging infectious diseases
58. Escherichia coli O157:H7 outbreaks in the United States, 1982-1996
59. Enterohemorrhagic Escherichia coli infections: Following transmission routes
60. Sporadic STEC O157 infection: Secondary household transmission in Wales
61. Lessons from a large outbreak of Escherichia coli O157:H7 infections: Insights into the infectious dose and method of widespread contamination of hamburger patties
62. A new route of transmission of Escherichia coli: Infection from dry fermented salami
63. Hospital-acquired Escherichia coli O157:H7 associated haemolytic uraemic syndrome in a nurse
64. A severe outbreak of E. coli O157:H7 in two psychogeriatric wards
65. Hospital outbreak of Escherichia coli O157:H7 associated with a rare phage type-Ontario
66. The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7
67. Nosocomial Escherichia coli O157 infection
68. Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center
69. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities
70. Escherichia coli O 157: Outbreak in a day nursery
71. Escherichia coli O157:H7 diarrhea in a nursing home: Clinical, epidemiological, and pathological findings
72. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home
73. Occurrence and survival of verocytotoxin-producing Escherichia coli O157 in raw cow's milk in The Netherlands
74. Destruction of Salmonella typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes in chicken manure by drying and/or gassing with ammonia
75. Survival of enterohemorrhagic Escherichia coli O157:H7 in bovine feces applied to lettuce and the effectiveness of chlorinated water as a disinfectant
76. Comparison of chemical treatments to eliminate enterohemorrhagic Escherichia coli O157:H7 on alfalfa seeds
77. Behavior of enterohemorrhagic Escherichia coli O157:H7 on alfalfa sprouts during the sprouting process as influenced by treatments with various chemicals
78. Reduction of Escherichia coli O157:H7 and Salmonella typhimurium on beef carcass surfaces using acidified sodium chlorite
79. Chlorine inactivation of Escherichia coli O157:H7
80. Inactivation of Escherichia coli O157:H7 and Listeria monocytogenes on plastic kitchen cutting boards by electrolyzed oxidizing water
81. Antimicrobial activity of home disinfectants and natural products against potential human pathogens
82. Infections associated with eating seed sprouts: An international concern
83. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
84. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
85. Helicobacter pylori
86. Helicobacter pylori
87. Helicobacter pylori and gastroduodenal disorders
88. A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States
89. Reservoirs of Helicobacter pylori and modes of transmission
90. Isolation of Helicobacter pylori from human faeces
91. Fecal and oral shedding of Helicobacter pylori from healthy infected adults
92. Helicobacter pylori infection and dental care
93. Dietary risk factors associated with the transmission of Helicobacter pylori in Lima, Peru
94. Water source as risk factor for Helicobacter pylori infection in Peruvian children
95. Endoscopic transmission of Helicobacter pylori
96. Is transmission of Campylobacter pylori by endoscopic examination possible?
97. Epidemic gastritis with hypochlorhydria
98. Epidemic hypochlorhydria
99. Endoscopic cross-infection with Helicobacter pylori
100. Transmission of Helicobacter pylori by endoscopy?
101. Effective reduction of Helicobacter pylori infection after upper gastroin-testinal endoscopy by mechanical washing of the endoscope
102. Patient-to-patient-transmission of Campylobacter pylori infection by fiberoptic gastro-duodenoscopy
103. H. pylori reinfection after successful eradication analyzed by RAPD or RFLP
104. Mouth-to-mouth resuscitation and Helicobacter pylori infection
105. Occupational exposure to Helicobacter pylori for the endoscopy professional: A sera epidemiological study
106. Epidemiology of Helicobacter pylori: Transmission, translocation and extragastric reservoirs
107. Coccoid Helicobacter pylori not culturable in vitro reverts in mice
108. Effect of physical environment on survival of Helicobacter pylori
109. Use of autoradiography to assess viability of Helicobacter pylori in water
110. Survival of Helicobacter pylori in milk and tap water
111. Presence of Helicobacter species DNA in Swedish water
112. Helicobacter pylori in the natural environment
113. Transmission of Helicobacter pylori infection via flexible fiberoptic endoscopy
114. Disinfection of biopsy forceps and culture of Helicobacter pylori from gastric mucosal biopsies
115. Are routine cleaning methods sufficient to remove Helicobacter pylori from endoscopic equipment?
116. Conventional cleaning and disinfection techniques eliminate the risk of endoscopic transmission of Helicobacter pylori
117. Efficacy of conventional endoscopic disinfection and sterilization methods against Helicobacter pylori contamination
118. Risk of iatrogenic transmission of Helicobacter pylori by gastroscopes
119. Detection of Helicobacter pylori DNA by PCR in gastrointestinal equipment
120. Inactivation of Helicobacter pylori by chlorination
121. Recommendations for prevention, (HCV) infection and HCV-related chronic disease
122. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
123. Hepatitis C infection in the United States
124. The risk of transfusion-transmitted viral infections
125. Hepatitis C infection and viremia in Dutch hemophilia patients
126. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin
127. HCV infection in patients with primary defects of immunoglobulin production
128. Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinemia
129. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin
130. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
131. Non-A, non-B hepatitis among recipients in a plasmapheresis stimulation program
132. Epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis center, I: Epidemiological observations
133. Transmission of HCV by organ transplantation
134. Bloodborne pathogen transmission in health care workers
135. Nosocomial transmission of hepatitis C virus
136. Primer on hepatitis C for hospital epidemiologists
137. Risk and management of blood-borne infections in health care workers
138. Hepatitis C virus infection in dialysis and renal transplantation
139. Hepatitis C virus in the hemodialysis setting: A review with recommendations for control
140. Blood-borne virus infections in dialysis units - A review
141. National surveillance of dialysis associated diseases in the United States, 1995
142. National surveillance of dialysis-associated diseases in the United States, 1997
143. Hepatitis C transmission in a hemodialysis unit: Molecular evidence for spread of virus among patients not sharing equipment
144. Hepatitis C in a hemodialysis unit: Molecular evidence for nosocomial transmission
145. Confirmation of nosocomial transmission of hepatitis C virus by phylogenetic analysis of the NS5-B region
146. Molecular epidemiology of hepatitis C virus outbreak in a haemodialysis unit
147. Molecular evidence for nosocomial transmission of hepatitis C in a French hemodialysis unit
148. Molecular evidence of nosocomial transmission of hepatitis C virus in a haemodialysis unit
149. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: Direct sequencing of HCV-HVR1 as an appropriate tool of phylogenetic analysis
150. Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients
151. Patient-to-patient transmission of hepatitis C virus during colonoscopy
152. Nosocomial transmission of hepatitis C virus
153. Hepatitis C after retrograde cholangiography
154. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service
155. Hepatitis C virus infection in institutionalized psychiatric patients: Possible role of transmission by razor sharing
156. Transmission of hepatitis KC virus during the ancillary procedures for assisted conception
157. Nosocomial transmission of hepatitis C virus
158. Investigation of possible patient-to-patient transmission of hepatitis C in a hospital
159. Revision of the anaesthetic aspects of an infection control policy following reporting of hepatitis C nosocomial infection
160. Hepatitis C nosocomial infection
161. Infection control: A reply to Prof E. S. Greene
162. Barriers to hepatitis C transmission within breathing systems: Efficacy of a pleated hydrophobic filter
163. Seroprevalence of antibodies to hepatitis C virus in high-risk personnel
164. Viral hepatitis in health care personnel at the Johns Hopkins Hospital
165. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons
166. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons
167. Occupational risk of hepatitis C infections among general dentists and oral surgeons in North America
168. Hepatitis C infection in medical personnel after needlestick injury
169. Transmission of hepatitis C via blood splash into conjunctiva
170. Simultaneous infection with HIV and hepatitis C virus following occupational conjunctival blood exposure
171. Hepatitis C virus transmission from health care worker to patient
172. Transmission of hepatitis C virus by a cardiac surgeon
173. Transmission of hepatitis C. virus from surgeon to patient prompts look-back
174. Survival of hepatitis B virus after drying and storage for one week
175. Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus
176. Evaluation of a disinfection procedure for hysteroscopes contaminated by hepatitis C virus
177. Risk of transmission of hepatitis C virus by digestive endoscopy
178. Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes
179. Risk of transmission of hepatitis C through endoscopy of the digestive tract